SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

74,294.96 -19.63
( -0.03%)

Global Indices

Nasdaq

51,699.28 -99.76
(-0.19%)

Dow Jones

7,668.45 9.69
(0.13%)

Hang Seng

65,040.24 903.99
(1.41%)

Nikkei 225

10,654.81 -161.33
(-1.49%)

Forex

USD-INR

95.87 0.21
(0.22%)

EUR-INR

110.00 -0.22
(-0.20%)

GBP-INR

128.18 -0.44
(-0.35%)

JPY-INR

0.61 0.00
(-0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glenmark Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532296

INE935A01035

855.7128074

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLENMARK

46.01

67169.47

EPS(TTM)

Face Value()

Div & Yield %

51.73

0.21

Back

axentra corp ltd

Foseco India consolidated net profit rises 56.02% in the March 2026 quarter

May 13,2026

Net profit of Foseco India rose 56.02% to Rs 33.81 crore in the quarter ended March 2026 as against Rs 21.67 crore during the previous quarter ended March 2025. Sales rose 35.94% to Rs 201.88 crore in the quarter ended March 2026 as against Rs 148.51 crore during the previous quarter ended March 2025.

Particulars	Quarter Ended
	Mar. 2026	Mar. 2025	% Var.
Sales	201.88	148.51	36
OPM %	20.48	18.38	-
PBDT	49.58	31.48	57
PBT	41.43	29.14	42
NP	33.81	21.67	56

74,294.96 -19.63 ( -0.03%)

51,699.28 -99.76 (-0.19%)

7,668.45 9.69 (0.13%)

65,040.24 903.99 (1.41%)

10,654.81 -161.33 (-1.49%)

95.87 0.21 (0.22%)

110.00 -0.22 (-0.20%)

128.18 -0.44 (-0.35%)

0.61 0.00 (-0.09%)